Výsledky vyhledávání - "Maria Malmenäs"

Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group

Autor: Elizabeth Manias, Adina Turcu-Stiolica, Lusine Abrahamyan, Amit D. Raval, John E. Zeber, Mickaël Hiligsmann, Bijan J. Borah, Maria Malmenäs, Andrew M. Peterson, Thomas J. Bunz, David S. Hutchins, Bryan Bennett, Priti P. Pednekar, Tamás Ágh, Allison Fiona Williams

Publikováno v: Value in Health. 22:139-156

Background A broad literature base exists for measuring medication adherence to monotherapeutic regimens, but publications are less extensive for measuring adherence to multiple medications. Objectives To identify and characterize the multiple medica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dad850d8e18ea21d4357b581a20bcb99
https://doi.org/10.1016/j.jval.2018.08.006

Zobrazit plný text záznamu

Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden

Autor: Per-Uno Malmström, Viktor Dansk, Mats Bläckberg, Maria Malmenäs

Publikováno v: Future Oncology. 12:1025-1038

Aim: This study explored the cost consequences of introducing hexaminolevulinate hydrochloride-guided blue-light flexible cystoscopy (HAL BLFC) as an adjunct to white-light flexible cystoscopy compared with white-light flexible cystoscopy alone, for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02ccb09f8b4733736064f4c0cc129d28
https://doi.org/10.2217/fon-2015-0021

Zobrazit plný text záznamu

Renal effects of the cyclooxygenase-inhibiting nitric oxide donator AZD3582 compared with rofecoxib and naproxen during normal and low sodium intake

Autor: D. Craig Brater, Maria Malmenäs, Ann Hedman, Bo Odlind, Lars I. Andersson, Gunilla Huledal, Bror Jonzon

Publikováno v: Clinical Pharmacology & Therapeutics. 77:437-450

Background Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase (COX) and can thereby reduce renal function, especially with respect to solute excretion and renal perfusion. AZD3582 [4-(nitrooxy)butyl-(2S)-2-(6-methoxy-2-naphthyl)prop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b842fdcb3bf524c3f00770eeca4afff
https://doi.org/10.1016/j.clpt.2005.01.011

Zobrazit plný text záznamu

Patient Evaluation of a Novel Non-Injectable Anesthetic Gel: A Multicenter Crossover Study Comparing the Gel to Infiltration Anesthesia During Scaling and Root Planing

Autor: Jan De Boever, Pierre Bercy, Elke Hendrickx, Daniel van Steenberghe, Lut Geers, Patrick Adriaens, Eric Rompen, Joakim Ramsberg, Christian Adriaenssen, Maria Malmenäs

Publikováno v: Journal of Periodontology. 75:1471-1478

Periodontal scaling procedures commonly require some kind of anesthesia. From the patient's perspective, the choice of anesthetic method is a trade-off between the degree of anesthesia and accepting the side effects. The present study evaluates the p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3133e7c66855b79c770ac9aef02e8742
https://doi.org/10.1902/jop.2004.75.11.1471

Zobrazit plný text záznamu

A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis

Autor: Jacek Szechinski, György Genti, Cesar Ramos-Remus, Stefan Lohmander, Maria Malmenäs, Asgar Ali Kalla, Lena Bolin, Douglas McKeith, Ola Svensson

Publikováno v: Annals of the Rheumatic Diseases; 64(3), pp 449-456 (2005)

To evaluate the gastrointestinal safety and efficacy of the COX inhibiting nitric oxide donator AZD3582 in patients with hip or knee osteoarthritis.970 patients were randomised (7:7:2) to AZD3582 750 mg twice daily, naproxen 500 mg twice daily, or pl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9545a297f77a55b13e756d3a468b2ec2
https://doi.org/10.1136/ard.2004.023572

Zobrazit plný text záznamu

Retrospective real-world adherence in patients with type 2 diabetes initiating once-daily liraglutide 1.8 mg or twice-daily exenatide 10 μg

Autor: Maria Malmenäs, Jakob Langer, Jonathan Bouchard

Publikováno v: Clinical therapeutics. 35(6)

The effectiveness of a drug is significantly influenced by a patient's adherence to the required regimen.The goal of this retrospective database analysis was to determine the factors affecting adherence over a 12-month follow-up period in adults with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::588e9449a935552f70aa0bd541ee2470
https://pubmed.ncbi.nlm.nih.gov/23642290

Zobrazit plný text záznamu

Impact of Measures to Enhance the Value of Observational Surveys in Rare Diseases: The Fabry Outcome Survey (FOS)

Autor: Gere Sunder-Plassmann, Perry M. Elliott, Roberto Giugliani, Michael Beck, Joe T.R. Clarke, E Hernberg-Stahl, Guillem Pintos-Morell, Maria Malmenäs

Publikováno v: Value in Health. (6):862-866

Background Disease registries are an important source of information on the natural history of rare diseases and the response to new therapies in a real-world setting. The value of the information, however, is directly related to the completeness of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acddf56c93924b98de0c0444aad7c6a3

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání